KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2016 - 2025)

Regeneron Pharmaceuticals has reported Asset Utilization Ratio over the past 16 years, most recently at 0.36 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.36 for Q4 2025, down 5.92% from a year ago — trailing twelve months through Dec 2025 was 0.36 (down 5.92% YoY), and the annual figure for FY2025 was 0.37, down 8.65%.
  • Asset Utilization Ratio for Q4 2025 was 0.36 at Regeneron Pharmaceuticals, down from 0.36 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for REGN hit a ceiling of 0.63 in Q2 2021 and a floor of 0.21 in Q4 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.37 (2025), compared with a mean of 0.38.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 63.77% in 2022 and later soared 93.59% in 2023.
  • Regeneron Pharmaceuticals' Asset Utilization Ratio stood at 0.46 in 2021, then plummeted by 54.63% to 0.21 in 2022, then soared by 93.59% to 0.4 in 2023, then decreased by 6.07% to 0.38 in 2024, then dropped by 5.92% to 0.36 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.36 (Q4 2025), 0.36 (Q3 2025), and 0.38 (Q2 2025) per Business Quant data.